Found: 17
Select item for more details and to access through your institution.
Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2017.01825
- By:
- Publication type:
- Article
Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 4, p. 1140, doi. 10.4143/crt.2016.491
- By:
- Publication type:
- Article
Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer.
- Published in:
- Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-02769-4
- By:
- Publication type:
- Article
Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3701, doi. 10.1007/s00262-021-03008-0
- By:
- Publication type:
- Article
A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 3994, doi. 10.3390/cancers13163994
- By:
- Publication type:
- Article
NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2659, doi. 10.3390/cancers12092659
- By:
- Publication type:
- Article
Immunotherapeutic Development of a Tri-Specific NK Cell Engager Recognizing BCMA.
- Published in:
- Immuno, 2023, v. 3, n. 2, p. 237, doi. 10.3390/immuno3020016
- By:
- Publication type:
- Article
The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation ( HCT).
- Published in:
- Immunological Reviews, 2014, v. 258, n. 1, p. 45, doi. 10.1111/imr.12157
- By:
- Publication type:
- Article
The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development.
- Published in:
- Immunological Reviews, 2009, v. 228, n. 1, p. 115, doi. 10.1111/j.1600-065X.2008.00746.x
- By:
- Publication type:
- Article
Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.711621
- By:
- Publication type:
- Article
Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy.
- Published in:
- Molecular Diagnosis & Therapy, 2021, v. 25, n. 5, p. 577, doi. 10.1007/s40291-021-00550-6
- By:
- Publication type:
- Article
The role of tec kinases in CD8+ T cell memory differentiation.
- Published in:
- FASEB Journal, 2008, v. 22, p. 511, doi. 10.1096/fasebj.22.2_supplement.511
- By:
- Publication type:
- Article
Role of Itk in γΔ T cell development and function.
- Published in:
- FASEB Journal, 2008, v. 22, p. 410, doi. 10.1096/fasebj.22.2_supplement.410
- By:
- Publication type:
- Article
Allogeneic NK cells eradicate myeloblasts but not neoplastic mast cells in systemic mastocytosis associated with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. E66, doi. 10.1002/ajh.24673
- By:
- Publication type:
- Article
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti–PD-1 therapy.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 568, p. 1, doi. 10.1126/scitranslmed.aaz5618
- By:
- Publication type:
- Article